ZIMMER BIOMET HOLDINGS, INC. Repayments of Debt
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Repayments of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-02-20
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for the quarter ending 2024-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for the quarter ending 2024-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for the quarter ending 2024-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for fiscal 2023 was $33.90M, a 86.04% decline from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. repayments of debt for fiscal 2022 was $242.90M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $0.00 derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $33.90M 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $33.90M 10-Q · filed 2024-10-30 | $33.90M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $33.90M 10-Q · filed 2024-08-07 | $33.90M derived: sum of 3 quarters · filed 2025-02-25 | |
| 2023-03-31 | $33.90M 10-Q · filed 2024-05-02 | $33.90M derived: sum of 2 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $242.90M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $242.90M 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |